Yun Gong, M.D.

Peer-Reviewed Articles

1. Xu H, Fan F, Gong Y, Jing X, Lin X, Wang H, Lin F, Li Z. Diagnostic Challenges in Fine-Needle Aspiration Cytology of Mediastinal Tumors and Lesions. Arch Pathol Lab Med 146(8):960-974, 2022. e-Pub 2022. PMID: 34402861.
2. Shen T, Zhao J, Zhao M, Taggart MW, Ramalingam P, Gong Y, Wu Y, Liu H, Zhang J, Resetkova E, Wang WL, Ding Q, Huo L, Yoon E. Unusual staining of immunohistochemical markers PAX8 and CDX2 in breast carcinoma: a potential diagnostic pitfall. Hum Pathol 125:35-47, 2022. e-Pub 2022. PMID: 35417734.
3. Villodre ES, Hu X, Eckhardt BL, Larson R, Huo L, Yoon EC, Gong Y, Song J, Liu S, Ueno NT, Krishnamurthy S, Pusch S, Tripathy D, Woodward WA, Debeb BG. NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis. J Natl Cancer Inst 114(4):579-591, 2022. e-Pub 2022. PMID: 34893874.
4. Holdener SL, Gong Y. Fine-needle aspiration of metastatic melanoma with signet-ring cell features. Diagn Cytopathol 49(10):1138-1140, 2021. e-Pub 2021. PMID: 34387939.
5. Huang X, Ding Q, Guo H, Gong Y, Zhao J, Zhao M, Sui D, Wu Y, Chen H, Liu H, Zhang J, Resetkova E, Moulder SL, Wang WL, Huo L. Comparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple-negative breast carcinoma. Hum Pathol 108:42-50, 2021. e-Pub 2021. PMID: 33221342.
6. Hu X, Villodre ES, Larson R, Rahal OM, Wang X, Gong Y, Song J, Krishnamurthy S, Ueno NT, Tripathy D, Woodward WA, Debeb BG. Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer. Commun Biol 4(1):72, 2021. e-Pub 2021. PMID: 33452400.
7. Khanlari M, Tang G, Hao S, Gong Y, Li S, Miranda RN, Lin P, Iyer S, Yin CC, Xie W, Vega F, Medeiros LJ, Xu J. Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement. Br J Haematol 192(1):e17-e21, 2021. e-Pub 2021. PMID: 33216956.
8. Villodre ES, Gong Y, Hu X, Huo L, Yoon EC, Ueno NT, Woodward WA, Tripathy D, Song J, Debeb BG. NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer. Cancers (Basel) 12(12):3711, 2020. e-Pub 2020.
9. Porteus C, Gan Q, Gong Y, Pantanowitz L, Henderson-Jackson E, Saeed-Vafa D, Mela N, Peterson D, Ahmad N, Ahmed A, Bui M. Sclerosing epithelioid fibrosarcoma: cytologic characterization with histologic, immunohistologic, molecular, and clinical correlation of 8 cases. J Am Soc Cytopathol 9(6):513-519, 2020. e-Pub 2020. PMID: 32624384.
10. Hou T, Gan Q, Joseph CT, Sun X, Gong Y. Insulinoma-associated protein 1 immunostaining for various types of neuroendocrine tumors on FNA smears. Cancer Cytopathol 128(10):725-732, 2020. e-Pub 2020. PMID: 32573984.
11. Guo H, Ding Q, Gong Y, Gilcrease MZ, Zhao M, Zhao J, Sui D, Wu Y, Chen H, Liu H, Zhang J, Resetkova E, Moulder SL, Wang WL, Huo L. Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors. Breast Cancer Res 22(1):69, 2020. e-Pub 2020. PMID: 32576238.
12. Chen L, Jing H, Gong Y, Tam AL, Stewart J, Staerkel G, Guo M. Diagnostic efficacy and molecular testing by combined fine-needle aspiration and core needle biopsy in patients with a lung nodule. Cancer Cytopathol 128(3):201-206, 2020. e-Pub 2020. PMID: 31913583.
13. Wang M, Kundu U, Gong Y. Pitfalls of FNA diagnosis of thymic tumors. Cancer Cytopathol 128(1):57-67, 2020. e-Pub 2020. PMID: 31742902.
14. Parmer RJ, Gong Y, Yoo SH, Miles LA. Neuroendocrine Targeting of Tissue Plasminogen Activator (t-PA). J Neurol Disord Stroke 7(1):1153, 2020. e-Pub 2020. PMID: 32549050.
15. Zhang J, Xiao C, Feng Z, Gong Y, Sun B, Li Z, Lu Y, Fei X, Wu W, Sun X, Teng L. SOX4 promotes the growth and metastasis of breast cancer. Cancer Cell Int 20:468, 2020. e-Pub 2020. PMID: 33005101.
16. Guo M, Khanna A, Wang J, Williams MD, Kalhor N, Gong Y, Xu L, Sturgis EM, Staerkel G. Incorporation of Cervista Human Papillomavirus 16/18 Assay Into Algorithms for Classifying Human Papillomavirus Status in Formalin Fixed Paraffin-Embedded Head and Neck Squamous Carcinoma Specimens. Arch Pathol Lab Med 143(3):356-361, 2019. e-Pub 2019. PMID: 30221979.
17. Gan Q, Joseph CT, Guo M, Zhang M, Sun X, Gong Y. Utility of NKX3.1 Immunostaining in the Detection of Metastatic Prostatic Carcinoma on Fine-Needle Aspiration Smears. Am J Clin Pathol 152(4):495-501, 2019. e-Pub 2019. PMID: 31175351.
18. Sinn BV, Fu C, Lau R, Litton J, Tsai TH, Murthy R, Tam A, Andreopoulou E, Gong Y, Murthy R, Gould R, Zhang Y, King TA, Viale A, Andrade V, Giri D, Salgado R, Laios I, Sotiriou C, Marginean EC, Kwiatkowski DN, Layman RM, Booser D, Hatzis C, Vicente Valero V, Fraser Symmans W. SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer. NPJ Breast Cancer 5:16, 2019. e-Pub 2019. PMID: 31231679.
19. Ding Q, Wang Y, Zuo Z, Gong Y, Krishnamurthy S, Li CW, Lai YJ, Wei W, Wang J, Manyam GC, Diao L, Zhang X, Lin F, Symmans WF, Sun L, Liu CG, Liu X, Debeb BG, Ueno NT, Harano K, Alvarez RH, Wu Y, Cristofanilli M, Huo L. Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer. Hum Pathol 77:121-129, 2018. e-Pub 2018. PMID: 29689244.
20. Noll B, Wang WL, Gong Y, Zhao J, Kalhor N, Prieto V, Staerkel G, Roy-Chowdhuri S. Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations. Cancer Cytopathol 126(5):342-352, 2018. e-Pub 2018. PMID: 29499101.
21. He J, Huo L, Ma J, Zhao J, Bassett RL, Sun X, Ueno NT, Lim B, Gong Y. Expression of Programmed Death Ligand 1 (PD-L1) in Posttreatment Primary Inflammatory Breast Cancers and Clinical Implications. Am J Clin Pathol 149(3):253-261, 2018. e-Pub 2018. PMID: 29425258.
22. Zhou X, Xu M, Zeng W, Chen Z, Lu G, Gong Y, Finnell RH, Xiao H, Qiao B, Wang H. Combined effects of FH (E404D) and ACOX2 (R409H) cause metabolic defects in primary cardiac malignant tumor. Cell Death Discov 4:18, 2018. e-Pub 2018. PMID: 30062063.
23. Wang X, Reyes ME, Zhang D, Funakoshi Y, Trape AP, Gong Y, Kogawa T, Eckhardt BL, Masuda H, Pirman DA, Yang P, Reuben JM, Woodward WA, Bartholomeusz C, Hortobagyi GN, Tripathy D, Ueno NT. EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer. Oncotarget 8(40):67904-67917, 2017. e-Pub 2017. PMID: 28978083.
24. Fujii T, Reuben JM, Huo L, Fernandez JRE, Gong Y, Krupa R, Suraneni MV, Graf RP, Lee J, Greene S, Rodriguez A, Dugan L, Louw J, Lim B, Barcenas CH, An M, Tripathy D, Wang Y, Landers M, Dittamore R, Ueno NT. Androgen receptor expression on circulating tumor cells in metastatic breast cancer. PLOS One 12:e0185231, 2017. e-Pub 2017. PMID: 28957377.
25. Kandukuri S, Lin F, Gui L, Gong Y, Fan F, Chen L, Cai G, Liu H. Application of immunohistochemistry in undifferentiated neoplasms: a practical approach. Arch Pathol Lab Med 141:1014-1032, 2017. e-Pub 2017. PMID: 28745568.
26. Guo M, Khanna A, Wang J, Dawlett MA, Kologinczak TL, Lyons GR, Bassett RL, Sneige N, Gong Y, Bevers TB. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening. Cancer Cytopathol 125(8):644-651, 2017. e-Pub 2017. PMID: 28498639.
27. Zhou H, Guo M, Gong Y. Challenge of FNA diagnosis of angiomyolipoma: a study of 33 cases. Cancer Cytopathology 125:257-266, 2017. e-Pub 2017. PMID: 28152270.
28. Sneige N, Hess KR, Multani AS, Gong Y, Ibrahim NK. Prognostic significance of equivocal human epidermal growth factor receptor 2 results and clinical utility of alternative chromosome 17 genes in patients with invasive breast cancer: A cohort study. Cancer 123:1115-1123, 2017. e-Pub 2017. PMID: 27893937.
29. Leng B, Guo M, Zhao J, Gong Y. Utility and Pitfalls of GATA3 Immunocytochemistry for Diagnosis of Metastatic Breast Carcinoma and Urothelial Carcinoma on Cytology Specimens. J Am Soc Cytopathol 6:73-79, 2017. e-Pub 2017. PMID: 31042637.
30. Wang H, Hoda RS, Faquin W, Rossi ED, Hotchandani N, Sun T, Pusztaszeri M, Bizzarro T, Bongiovanni M, Patel V, Jhala N, Fadda G, Gong Y. FNA biopsy of secondary nonlymphomatous malignancies in salivary glands: A multi-institutional study of 184 cases. Cancer Cytopathol 125:91-103, 2017. e-Pub 2017. PMID: 28001329.
31. Alexander A, Karakas C, Chen X, Carey J, Yi M, Bondy M, Thompson P, Cheung L, Ellis LO, Gong Y, Krishnamurthy S, Alvarez R, Ueno NT, Hunt KK, Keyomarsi K. Cyclin E Overexpression as a Biomarker for Combination Treatment Strategies in Inflammatory Breast Cancer. Oncotarget 28:14897-14911, 2017. e-Pub 2017. PMID: 28107181.
32. Amy Chen YJ, Lin CY, Feng J, Cogdell D, Zhang W, Liu J, Sneige N, Gong Y, Guo M. Accuracy of EasyChip HPV blot genotyping assay to detect high-risk HPV genotypes in SurePath Papanicolaou specimens. J Am Soc Cytopathol 5(6):351-358, 2016. e-Pub 2016. PMID: 31042547.
33. Arun BK, Gong Y, Liu D, Litton JK, Gutierrez-Barrera AM, Jack Lee J, Vornik L, Ibrahim NK, Cornelison T, Hortobagyi GN, Heckman-Stoddard BM, Koenig KB, Alvarez RR, Murray JL, Valero V, Lippman SM, Brown P, Sneige N. Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer. Breast Cancer Res Treat 158:67-77, 2016. e-Pub 2016. PMID: 27287781.
34. Guo M, Khanna A, Dawlett M, Patel S, Gong Y, Staerkel G. Efficacy of reflex HPV16/18 genotyping in predicting CIN3/VAIN3 in women with HPV+/Pap– results. J Am Soc Cytopathol 5:31-36, 2016. e-Pub 2016. PMID: 31042536.
35. Huo L, Wang Y, Gong Y, Krishnamurthy S, Wang J, Diao L, Liu CG, Liu X, Lin F, Symmans WF, Wei W, Zhang X, Sun L, Alvarez RH, Ueno NT, Fouad TM, Harano K, Debeb BG, Wu Y, Reuben J, Cristofanilli M, Zuo Z. MicroRNA Expression Profiling Identifies Decreased Expression of miR-205 in Inflammatory Breast Cancer. Mod Pathol 29:330-42, 2016. e-Pub 2016. PMID: 26916073.
36. Kono M, Fujii T, Lyons GV, Huo L, Bassett R, Gong Y, Karuturi MS, Tripathy D, Ueno NT. Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy. Breast Cancer Res Treat 160:101-09, 2016. e-Pub 2016. PMID: 27663436.
37. Huo L, Gong Y, Guo M, Gilcrease MZ, Wu Y, Zhang H, Zhang J, Resetkova E, Hunt KK, Deavers MT. GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry. Histopathology 67(2):245-54, 2015. e-Pub 2015. PMID: 25564996.
38. De Vivar AD, Dawlett M, Wang JP, Jack A, Gong Y, Staerkel G, Guo M. Clinical performance of hybrid capture 2 human papillomavirus testing for recurrent high-grade cervical/vaginal intraepithelial neoplasm in patients with an ASC-US Papanicolaou test result during long-term posttherapy follow-up monitoring. Arch Pathol Lab Med 139(2):219-24, 2015. e-Pub 2015. PMID: 25611104.
39. Tsai CJ, Li J, Gonzalez-Angulo AM, Allen PK, Woodward WA, Ueno NT, Lucci A, Krishnamurthy S, Gong Y, Yang W, Cristofanilli M, Valero V, Buchholz, TA. Outcomes after multidisciplinary treatment of inflammatory breast cancer in the era of neoadjuvant HER2-directed therapy. Am J Clin Oncol 38:242-7, 2015. e-Pub 2015. PMID: 23648437.
40. Lacerda L, Debeb BG, Smith D, Larson R, Solley T, Xu W, Krishnamurthy S, Gong Y, Levy LB, Buchholz T, Ueno NT, Klopp A, Woodward WA. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a pre-clinical model. Breast Cancer Res 17:42, 2015. e-Pub 2015. PMID: 25887413.
41. Mallampati S, Leng X, Ma H, Zeng J, Li J, Wang H, Lin K, Lu Y, Yang Y, Sun B, Gong Y, Lee J, Konopleva M, Andreeff M, Arlinghaus RB, Cai Z, Fang B, Shen H, Han X, Hirsch-Ginsberg CF, Gao X, Paranjape AN, Mani SA, Clise-Dwyer K, Sun X. Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemia. Blood 125:2968-2973, 2015. e-Pub 2015. PMID: 25712988.
42. Zhang YH, Liu CJ, Dawlett M, Guo M, Sun X, Gong Y. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples. Cancer Cytopathol 122:892-7, 2014. e-Pub 2014. PMID: 25056830.
43. Gong Y, Wang J, Huo L, Wei W, Ueno NT, Woodward WA. Aldehyde dehydrogenase 1 (ALDH1) expression in inflammatory breast cancer as measured by immunohistochemical staining. Clin Breast Cancer 14:e81-8, 2014. e-Pub 2014. PMID: 24461456.
44. Guo M, Khanna A, Dhillon J, Patel S, Feng J, Williams MD, Bell DM, Gong Y, Katz, RL, Sturgis EM, Staerkel GA. Cervista HPV assays for fine-needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma. Cancer Cytopathol 122:96-103, 2014. e-Pub 2014. PMID: 24339259.
45. Liu H, Shi J, Prichard JW, Gong Y, Lin F. Immunohistochemical evaluation of GATA-3 expression in ER-negative breast carcinomas. Am J Clin Pathol 141:648-55, 2014. e-Pub 2014. PMID: 24713735.
46. Gong Y, Wei Y, Wu Y, Ueno NT, Huo L. Expression of androgen receptor in inflammatory breast cancer and its clinical relevance. Cancer 120:1775-9, 2014. e-Pub 2014. PMID: 24634055.
47. Woodward WA, Krishnamurthy S, Lodhi A, Xiao L, Gong Y, Cristofanilli M, Buchholz TA, Lucci A. Aldehyde dehydrogenase 1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cells. J Cancer 5:360-7, 2014. e-Pub 2014. PMID: 24799954.
48. Liao B, Kamiya-Matsuoka C, Gong Y, Chen M, Wolf BA, Fowler NH. Primary natural killer/T-cell lymphoma presenting as leptomeningeal disease. J Neurol Sci 343:46-50, 2014. e-Pub 2014. PMID: 24880537.
49. Clevenger J, Joseph C, Dawlett M, Guo M, Gong Y. Reliability of immunostaining using pan-melanoma cocktail, SOX10, and MITF in confirming a diagnosis of melanoma on fine-needle aspiration smears. Cancer Cytopathol 122:779-85, 2014. e-Pub 2014. PMID: 24954720.
50. Singh M, Ding Y, Zhang L, Song D, Gong Y, Adams S, Ross DS, Wang J, Gorover S, Doval DC, Shao C, He Z, Chang V, Deng FM, Zhang D, Zu R, Lee P. Distinct breast cancer subtypes in women with early-onset disease across races. Am J Cancer Res 4:337-52, 2014. e-Pub 2014. PMID: 24954720.
51. Ma H, Mallampati S, Lu Y, Sun B, Wang E, Leng X, Gong Y, Shen H, Yin CC, Jones D, Amin HM, You MJ, Zweidler-McKay P, Ma Y, Kantarjian HM, Arlinghaus RB, Glassman A, Sun X. Sox4/Tcf711 Axis promotes progression of BCR-ABL+Acute lymphoblastic leukemia. Haematologica 99:1591-8, 2014. e-Pub 2014. PMID: 24997151.
52. Mallampati S, Sun B, Lu Y, Ma H, Gong Y, Wang D, Lee JS, Lin K, Sun X. Integrated genetic approaches identify the molecular mechanism of SOX4 in early B-cell development: intricate roles for RAG1/2 and CK1ε. Blood 123:4064-76, 2014. e-Pub 2014. PMID: 24786772.
53. Debeb B, Gong Y, Atkinson R, Sneige N, Huo L, Gonzalez-Angulo A, Hung M, Valero V, Ueno N, Woodward W. EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer. J Exp Clin Cancer Res 33:58, 2014. e-Pub 2014. PMID: 25051981.
54. Guo M, Khanna A, Feng J, Patel S, Zhang W, Gong Y, Huo L, Staerkel G. Analytical performance of cervista HPV 16/18 in SurePath pap specimens. Diagn Cytopathol 43:301-6, 2014. e-Pub 2014.
55. Wang X, Saso H, Iwamoto T, Xia W, Gong Y, Pusztai L, Woodward WA, Reuben JM, Warner SL, Bearss DJ, Hortobagyi GN, Hung MC, Ueno NT. Tazarotene-induced gene 1 promotes tumorigenicity and invasiveness of inflammatory breast cancer through receptor tyrosine kinase axl. Cancer Res 73:6516-25, 2013. e-Pub 2013. PMID: 24014597.
56. Zhao L, Gong Y, Wang J, Dawlett M, Huo L, Caraway NP, Guo M. Ultrasound-guided fine-needle aspiration biopsy of thyroid bed lesions from patients with thyroidectomy for thyroid carcinomas. Cancer Cytopathol 121:101-7, 2013. e-Pub 2013. PMID: 22605565.
57. Li X, Deavers MT, Guo M, Liu P, Gong Y, Albarracin CT, Middleton LP, Huo L. The effect of prolonged cold ischemia time on estrogen receptor immunohistochemistry in breast cancer. Mod Pathol 26:71-8, 2013. e-Pub 2013. PMID: 22899286.
58. Atiq M, Bhutani MS, Ross WA, Raju GS, Gong Y, Tamm EP, Javle M, Wang X, Lee JH. Role of Endoscopic Ultrasonography in Evaluation of Metastatic Lesions to the Pancreas: A Tertiary Cancer Center Experience. Pancreas 42:516-23, 2013. e-Pub 2013. PMID: 23211369.
59. Wang J, Katz RL, Stewart J, Landon G, Guo M, Gong Y. Fine needle aspiration diagnosis of lymphomas with signet ring cell features: a potential pitfalls and solutions. Cancer Cytopathol 121:525-32, 2013. e-Pub 2013. PMID: 23536424.
60. Krishnamurthy S, Woodward W, Yang W, Reuben JM, Tepperberg J, Ogura D, Niwa S, Huo L, Gong Y, El-Zein R, Gonzalez-Angulo AM, Chavez Mac Gregor M, Alvarez R, Lucci A, Valero V, Ueno NT. Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma. SpringerPlus 2:409, 2013. e-Pub 2013. PMID: 24156086.
61. Sun B, Mallampati S, Gong Y, Wang D, Lefebvre V, Sun X. Sox4 is required for the survival of pro-B cells. J Immunol 190:2080-89, 2013. e-Pub 2013. PMID: 23345330.
62. Guo M, Gong Y, Wang J, Dawlett M, Patel S, Liu P, Bevers TB, Sneige N. HPV 16/18 Genotyping Can Improve Risk Profiling in Women with Mildly Abnormal Pap Results. Cancer Cytopathol 121:79-85, 2013. e-Pub 2013. PMID: 23225501.
63. Huo L, Zhang J, Gilcrease MZ, Gong Y, Wu Y, Zhang H, Resetkova E, Hunt KK, Deavers MT. Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer. Histopathol 62:267-74, 2013. e-Pub 2013. PMID: 22963676.
64. Yang Y, Mallampati S, Sun B, Zhang J, Kim SB, Lee JS, Gong Y, Cai Z, Sun X. Wnt pathway contributes to the protection by bone marrow stromal cells of acute lymphoblastic leukemia cells and is a potential therapeutic target. Cancer Lett 333:9-17, 2013. e-Pub 2013. PMID: 23333798.
65. Alvarez RH, Gong Y, Ueno NT, Alizadeh PA, Hortobagyi GN, Valero V. Metastasis in the breast mimicking inflammatory breast cancer. J Clin Oncol 30(22):e202-6, 2012. e-Pub 2012. PMID: 22734030.
66. Niikura N, Liu J, Hayashi N, Mittendorf EA, Gong Y, Palla SL, Tokuda Y, Gonzalez-Angulo AM, Hortobagyi GN, Ueno NT. Loss of HER2 expression in metastatic sites of HER2-overexpressing primary breast tumors. J Clin Oncol 30:593-9, 2012. e-Pub 2012. PMID: 22124109.
67. Atiq M, Gong Y, Raju GS, Lee JH. Pancreatic endocrine microadenomatosis in a patient with oculo-facio-cardio-dental syndrome (OFCD). Pancreas 41:327-29, 2012. e-Pub 2012. PMID: 22343980.
68. Zhao L, Guo M, Sneige N, Gong Y. Value of PAX8 and WT1 immunostaining in confirming the ovarian origin of metastatic carcinoma in serous effusion specimens. Am J Clin Pathol 137:304-9, 2012. e-Pub 2012. PMID: 22261458.
69. Zhao Q, Rashid A, Gong Y, Katz MH, Lee JE, Wolf R Balachandran A, Varadhachary GR, Pisters PWT, Wang H, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Pathologic Complete Response to Neoadjuvant Therapy in Patients with Pancreatic Ductal Adenocarcinoma Is Associated with Better Prognosis. Ann Diagn Pathol 16:29-37, 2012. e-Pub 2012. PMID: 22050964.
70. Atiq M, Bhutani MS, Bektas M, Lee JE, Gong Y, Tamm EP, Shah CP, Ross WA, Yao J, Raju GS, Wang X, Lee JH. EUS-FNA for Pancreatic Neuroendocrine Tumors - A tertiary cancer center experience. Dig Dis Sci 57:791-800, 2012. e-Pub 2012. PMID: 21964743.
71. Kurian EM, Dawlett M, Wang J, Gong Y, Guo M. The triage efficacy of fine needle aspiration biopsy for follicular variant of papillary thyroid carcinoma using the Bethesda reporting guidelines. Diagn Cytopathol 40:E69-73, 2012. e-Pub 2012. PMID: 21538966.
72. Kundu UR, Guo M, Landon G, Wu Y, Sneige N, Gong Y. Fine needle aspiration cytology of sclerosing adenosis of the breast: a retrospective review of cytologic features in conjunction with corresponding histologic features and radiologic findings. Am J Clin Pathol 138:96-102, 2012. e-Pub 2012. PMID: 22706864.
73. Zhang J, Li G, Li Z, Yu X, Zheng Y, Jin K, Wang H, Gong Y, Sun X, Teng X, Cao J, Teng L. Estrogen-independent effects of ER-α36 in ER-negative breast cancer. Steroids 77:666-73, 2012. e-Pub 2012. PMID: 22402113.
74. Sneige N, Thomison JB, Malpica A, Gong Y, Ensor J, Silva EG. Peritoneal washing cytologic analysis of ovarian serous tumors of low malignant potential to detect peritoneal implants and predict clinical outcome. Cancer Cytopathol 120:238-44, 2012. e-Pub 2012. PMID: 22826172.
75. Arias-Pulido H, Chaher N, Gong Y, Qualls C, Vargas J, Royce M. Tumor stroma vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer. BMC Cancer 12:298, 2012. e-Pub 2012. PMID: 22813402.
76. Antic T, Gong Y, Sneige N. Tumor type and single-cell/mesothelial-like cell pattern of breast carcinoma metastases in pleural and peritoneal effusions. Diagn Cytopathol 40:311-15, 2012. e-Pub 2012. PMID: 21104845.
77. Gong Y, Han EY, Guo M, Pusztai L, Sneige N. Stability of estrogen receptor status in breast carcinoma: a comparison between primary and metastatic tumors with regard to disease course and intervening systemic therapy. Cancer 117:705-13, 2011. e-Pub 2011. PMID: 20939012.
78. Ergin AB, Cristofanilli M, Daw H, Tahan G, Gong Y. Recurrent granulomatous mastitis mimicking inflammatory breast cancer. BMJ Case Rep Jan 2011:bcr0720103156, 2011. e-Pub 2011. PMID: 22715267.
79. Han J, Baik N, Kim KH, Yang JM, Han GW, Gong Y, Jardi M, Castellino FJ, Felez J, Parmer RJ, Miles LA. Monoclonal antibodies detect receptor-induced binding sites in glu-plasminogen. Blood 118:1653-62, 2011. e-Pub 2011. PMID: 21680799.
80. Hatzis C, Pusztai, L Valero V, Booser DJ, Esserman L, Lluch A, Vidaurre T, Holmes F, Souchon E, Martin M, Cotrina J, Gomez H, Hubbard R, Ferrer-Lozano J, Dyer R, Buxton M, Gong Y, Wu Y, Ibrahim N, Andreopoulou E, Ueno N, Hunt K, Yang W, Nazario A, DeMichele A, O'Shaughnessy J, Hortobagyi GN, Symmans WF. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA (Journal of the American Medical Association) 305:1873-881, 2011. e-Pub 2011. PMID: 21558518.
81. Gong Y, Huo L, Liu P, Sneige N, Sun X, Ueno NT, Lucci A, Buchholz TA, Valero V, Cristofanilli M. Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome. Cancer 117:5476-84, 2011. e-Pub 2011. PMID: 21713757.
82. Billah S, Stewart J, Staerkel G, Chen S, Gong Y, Guo M. EGFR and KRAS mutations in lung carcinoma: Molecular testing by using cytology specimens. Cancer Cytopathol 119:111-17, 2011. e-Pub 2011. PMID: 21400670.
83. Xiao L, Wang Y, Gong Y, Guo C. The TMPRSS2-ERG Gene Fusion in Metastatic Prostate Cancers: A Study of Fine Needle Aspiration Specimens. Zhonghua Bing Li Xue Za Zhi (In Chinese) 40:392-96, 2011. e-Pub 2011. PMID: 21914348.
84. Iwamoto T, Bianchini G, Qi Y, Cristofanilli M, Lucci A, Woodward WA, Reuben JM, Matsuoka J, Gong Y, Krishnamurthy S, Valero V, Hortobagyi GN, Robertson F, Symmans WF, Pusztai L, Ueno NT. Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer. Breast Cancer Res Treat 125:785-95, 2011. e-Pub 2011. PMID: 21153052.
85. Li J, Gonzalez-Angulo AM, Allen PK, Yu TK, Woodward WA, Ueno NT, Lucci A, Krishnamurthy S, Gong Y, Bondy ML, Yang W, Willey JS, Cristofanilli M, Valero V, Buchholz TA. Triple-Negative/Basal Subtype Predicts Poor Overall Survival and High Locoregional Relapse in Inflammatory Breast Cancer. Oncologist 16:1675-83, 2011. e-Pub 2011. PMID: 22147002.
86. Guo M, Warriage I, Mutyala B, Patel S, Lin E, Gong Y, Sneige N. Evaluation of p16 immunostaining to predict high-grade cervical intraepithelial neoplasia in women with Pap results of atypical squamous cells of undetermined significance. Diagn Cytopathol 39:482-88, 2011. e-Pub 2011. PMID: 20607682.
87. Xiao C, Gong Y, Han EY, Gonzalez-Angulo AM, Sneige N. Stability of HER2-positive status in breast carcinoma: a comparison between primary and paired metastatic tumors with regard to the possible impact of intervening trastuzumab treatment. Ann Oncol 22:1547-53, 2011. e-Pub 2011. PMID: 21239403.
88. Dawood S, Gong Y, Broglio K, Buchholz TA, Woodward W, Lucci A, Valero V, Gonzalez-Angulo AM, Hortobagyi GN, Cristofanilli M. Trastuzumab in primary inflammatory breast Cancer (IBC): high pathological response rates and improved outcome. Breast J e-pub, 2010. e-Pub 2010. PMID: 20626396.
89. Arias-Pulido H, (co-first author) GY, Joste N, Lomo L, Lee S, Verschraegen C, Lara J, Prossnitz E, Cristofanilli M, Royce M. GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer. Breast Cancer Res Treat 123:51-8, 2010. e-Pub 2010. PMID: 19902352.
90. Gu F, Ma Y, Fan Y, Lang R, Ding T, Hao X, Gong Y, Kobayashi H, Fang Z, Fu L. Synovial sarcoma individual chemotherapy directed by collagen gel droplet embedded culture drug sensitivity test: A case report. Oncology Letters 1:885-88, 2010. e-Pub 2010. PMID: 22966400.
91. Xiao C, Gong Y, Fu L. Research and clinical management of inflammatory breast carcinoma: Current status and future direction. Chin J Breast Dis 4:22-5, 2010. e-Pub 2010. PMID: 20193452.
92. Tabchy A, Valero V, Vidaurre T, Lluch A, Gomez H, Martin M, Qi Y, Barajas-Figueroa L, Souchon E, Coutant C, Doimi FD, Ibrahim NK, Gong Y, Hortobagyi GN, Hess K, Symmans WF, Pusztai L. Evaluation of the performance of a 30-gene paclitaxel, 5-fluroruracil, doxorubicin and cyclophosphamide (T/FAC) chemotherapy response predictor in a randomized clinical trial in breast cancer. Clin Cancer Res 16:5351-61, 2010. e-Pub 2010. PMID: 20829329.
93. Pusztai L, Jeong J, Gong Y, Ross J, Kim C, Hortobagyi GN, Paik S, Symmans WF. Evaluation of Microtubule-Associated Protein-Tau Expression As a Prognostic and Predictive Marker in the NSABP-B 28 Randomized Clinical Trial. J Clin Oncol 27:4287-92, 2009. e-Pub 2009. PMID: 19667268.
94. Ge Y, Sneige N, Eltorky MA, Wang Z, Lin E, Gong Y, Guo M. Immunohistochemical characterization of subtypes of male breast carcinoma. Breast Cancer Res 14;11:R28, 2009. e-Pub 2009. PMID: 19442295.
95. Payne M, Staerkel G, Gong Y. Indeterminate diagnosis in fine-needle aspiration of the pancreas: reasons and clinical implications. Diagn Cytopathol 37:21-9, 2009. e-Pub 2009. PMID: 18973122.
96. Gong Y, Sweet W, Duh YJ, Greenfield L, Fang Y, Zhao J, Tarco E, Symmans WF, Isola J, Sneige N. Chromogenic in situ hybridization (CISH) is a reliable method for detecting HER2 gene status in breast cancer: a multicenter study using conventional scoring criteria and the new ASCO/CAP recommendations. Am J Clin Pathol 131:490-97, 2009. e-Pub 2009. PMID: 19289584.
97. Gong Y, Sweet W, Duh YJ, Greenfield L, Tarco E, Trivedi S, Symmans WF, Isola J, Sneige N. Performance of chromogenic in situ hybridization on testing HER2 status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) HercepTest: a study of two institutions using conventional and the new ASCO/CAP scoring criteria. Am J Clin Pathol 132:228-36, 2009. e-Pub 2009. PMID: 19605817.
98. Guo M, Gong Y, Deavers M, Silva EG, Jan YJ, Cogdell DE, Luthra R, Lin E, Lai HC, Zhang W, Sneige N. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma. J Clin Microbiol 46:274-80, 2008. e-Pub 2008. PMID: 17977987.
99. Dawood S, Broglio K, Gong Y, Yang WT, Cristofanilli M, Kau SW, Meric FB, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo A. Prognostic significance of HER2 status in women with inflammatory breast cancer. Cancer 112:1905-11, 2008. e-Pub 2008. PMID: 18300243.
100. Guo M, Lin CY, Gong Y, Cogdell DE, Zhang W, Lin E, Sneige N. Human papillomavirus genotyping for the eight oncogenic types can improve specificity of HPV testing in women with mildly abnormal pap results. Mod Pathol 21:1037-43, 2008. e-Pub 2008. PMID: 18500260.
101. Uzquiano MC, Prieto VG, Nash JW, Ivan DS, Gong Y, Lazar AJ, Diwan AH. Metastatic basal cell carcinoma exhibits reduced actin expression. Mod Pathol 21:540-43, 2008. e-Pub 2008. PMID: 18223552.
102. Piao Y, Guo M, Gong Y. Diagnostic challenges of metastatic spindle cell melanoma on fine-needle aspiration specimens. Cancer 114:94-101, 2008. e-Pub 2008. PMID: 18260089.
103. Angeles R, Gong Y. Fine-needle aspiration of a subcutaneous gouty tophus. Diagn Cytopathol 36:494-95, 2008. e-Pub 2008. PMID: 18528887.
104. Arun B, Logan C, Broglio K, Yin C, Valero V, Kuerer H, Meric-Bernstam F, Gong Y, Browne D, Hortobagyi GN, Sneige N. Comparison of ductal lavage and random periareolar fine-needle aspiration as tissue acquisition methods in early breast cancer prevention trials. Clin Cancer Res 13:4943-48, 2007. e-Pub 2007. PMID: 17699874.
105. Gong Y, Yan K, Lin F, Anderson K, Sotiriou C, Andre F, Holmes FA, Valero V, Booser D, Pippen JE, Vukelja S, Gomez H, Mejia J, Barajas LJ, Hess KR, Sneige N, Hortobagyi GN, Pusztai L, Symmans WF. Determination of estrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study. Lancet Oncol 8:203-11, 2007. e-Pub 2007. PMID: 17329190.
106. Cabioglu N, (co-first author) GY, Islam R, Broglio KR, Sneige N, Sahin A, Gonzalez-Angulo AM, Morandi P, Bucana C, Hortobagyi GN, Cristofanilli M. Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer. Ann Oncol 18:1021-29, 2007. e-Pub 2007. PMID: 17351259.
107. Ren R, Guo M, Sneige N, Moran CA, Gong Y. Fine-needle aspiration of adrenal cortical carcinoma: cytologic spectrum and diagnostic challenges. Am J Clin Pathol 126(3):389-98, 2006. e-Pub 2006. PMID: 16880150.
108. Gong Y, Joseph T, Sneige N. Author reply to a comment regarding validation of commonly used immunostains on cell-transferred cytologic specimens. Cancer 108:135-36, 2006. e-Pub 2006.
109. Huang P, Staerkel G, Sneige N, Gong Y. Fine-needle aspiration of pancreatic serous cystadenoma: cytologic features and diagnostic pitfalls. Cancer 108:239-49, 2006. e-Pub 2006. PMID: 16691573.
110. Gonzalez-Angulo AM, Guarneri V, Gong Y, Cristofanilli M, Morales-Vasquez F, Sneige N, Hortobagyi G, Esteva FJ. Downregulation of the cyclin-dependent kinase inhibitor p27kip1 might correlate with poor disease-free and overall survival in inflammatory breast cancer. Clin Breast Cancer 7:326-30, 2006. e-Pub 2006. PMID: 17092400.
111. Sneige N, Liu B, Yin G, Gong Y, Arun BK. Correlation of cytologic findings and chromosomal instability detected by fluorescence in situ hybridization in breast fine-needle aspiration specimens from women at high risk for breast cancer. Mod Pathol 19:622-29, 2006. e-Pub 2006. PMID: 16528376.
112. Gong Y, Caraway N, Stewart J, Staerkel G. Metastatic ductal adenocarcinoma of the prostate: cytologic features and clinical findings. Am J Clin Pathol 126:302-9, 2006. e-Pub 2006. PMID: 16891207.
113. Alrahwan D, Staerkel G, Gong Y. Fine needle aspiration cytology of a metastatic duct carcinoma of the prostate: a case report. Acta Cytol 50:469-72, 2006. e-Pub 2006. PMID: 16901017.
114. Gong Y, Sneige N, Guo M, Hicks ME, Moran CA. Transthoracic fine-needle aspiration vs concurrent core needle biopsy in diagnosis of intrathoracic lesions: a retrospective comparison of diagnostic accuracy. Am J Clin Pathol 125:438-44, 2006. e-Pub 2006. PMID: 16613349.
115. Anderson K, Hess KR, Kapoor M, Tirrell S, Courtemanche J, Wang B, Wu Y, Gong Y, Hortobagyi GN, Symmans WF, Pusztai L. Reproducibility of gene expression signature-based predictions in replicate experiments. Clin Cancer Res 12:1721-27, 2006. e-Pub 2006. PMID: 16551855.
116. Gong Y, Sun X. Fine-needle aspiration of a presacral myelolipoma. Diagn Cytopathol 34(1):29-30, 2006. e-Pub 2006. PMID: 16355397.
117. Gong Y, Ren R, Ordonez NG, Sun X, Sneige N. Fine needle aspiration cytology of well-differentiated papillary mesothelioma: a case report. Acta Cytol 49(5):537-42, 2005. e-Pub 2005. PMID: 16334033.
118. Gong Y, Joseph T, Sneige N. Validation of commonly used immunostains on cell-transferred cytologic specimens. Cancer 105(3):158-64, 2005. e-Pub 2005. PMID: 15852338.
119. Gong Y, Jalali M, Staerkel G. Fine needle aspiration cytology of a thyroid metastasis of metaplastic breast carcinoma: a case report. Acta Cytol 49(3):327-30, 2005. e-Pub 2005. PMID: 15966298.
120. Gong Y, Krishnamurthy S. Fine-needle aspiration of an unusual case of poorly differentiated insular carcinoma of the thyroid. Diagn Cytopathol 32(2):103-7, 2005. e-Pub 2005. PMID: 15637672.
121. Gong Y, Gilcrease M, Sneige N. Reliability of chromogenic in situ hybridization for detecting HER-2 gene status in breast cancer: comparison with fluorescence in situ hybridization and assessment of interobserver reproducibility. Mod Pathol 18:1015-21, 2005. e-Pub 2005. PMID: 15861212.
122. Gong Y, Booser DJ, Sneige N. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma. Cancer 103:1763-69, 2005. e-Pub 2005. PMID: 15786420.
123. Gong Y, Sun X, Huo L, Wiley EL, Rao MS. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast. Histopathol 46:24-30, 2005. e-Pub 2005. PMID: 15656882.
124. Ren R, Sun X, Staerkel G, Sneige N, Gong Y. Fine-needle aspiration cytology of a liver metastasis of follicular dendritic cell sarcoma. Diagn Cytopathol 32(1):38-43, 2005. e-Pub 2005. PMID: 15584048.
125. Sun X, Peterson LC, Gong Y, Traynor AE, Nelson BP. Post-transplant plasma cell myeloma and polymorphic lymphoproliferative disorder with monoclonal serum protein occurring in solid organ transplant recipients. Mod Pathol 17(4):389-94, 2004. e-Pub 2004. PMID: 14976525.
126. Kidwai N, Gong Y, Sun X, Deshpande CG, Yeldandi A, Rao MS, Badve S. Expression of androgen receptor and prostate-specific antigen in male breast carcinoma. Breast Cancer Res 6:R18-23, 2004. e-Pub 2004. PMID: 14680496.
127. Gong Y, Symmans WF, Krishnamurthy S, Patel S, Sneige N. Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma. Cancer 102:34-40, 2004. e-Pub 2004. PMID: 14968416.
128. Gong Y, DeFrias DV, Nayar R. Pitfalls in fine needle aspiration cytology of extraadrenal paraganglioma. A report of 2 cases. Acta Cytol 47(6):1082-6, 2003. e-Pub 2003. PMID: 14674085.
129. Sun X, Gong Y, Pins MR. Pathologic quiz case: a paratesticular mass in a 55-year-old man. Arch Pathol Lab Med 127:e111-12, 2003. e-Pub 2003. PMID: 12562270.
130. Gong Y, Caraway N, Gu J, Zaidi T, Fernandez R, Sun X, Huh YO, Katz RL. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping. Cancer 99:385-93, 2003. e-Pub 2003. PMID: 14681948.
131. Miles LA, Castellino FJ, Gong Y. Critical role for conversion of glu-plasminogen to lys-plasminogen for optimal stimulation of plasminogen activation on cell surfaces. Trends Cardiovasc Med 13:21-30, 2003. e-Pub 2003. PMID: 12554097.
132. Gong Y, Sun X, Michael CW, Attal S, Williamson BA, Bedrossian CW. Immunocytochemistry of serous effusion specimens: a comparison of ThinPrep vs cell block. Diagn Cytopathol 28:1-5, 2003. e-Pub 2003. PMID: 12508174.
133. Zhang L, Gong Y, Grella DK, Castellino FJ, Miles LA. Endogenous plasmin converts glu-plasminogen to lys-plasminogen on the monocytoid cell surface. J Thromb Haemost 1:1264-70, 2003. e-Pub 2003. PMID: 12871329.
134. Gong Y, Sun X, Haines GK III, Pins MR. Renal cell carcinoma, chromophobe type, with collecting duct carcinoma and sarcomatoid components. Arch Pathol Lab Med 127:e38-40, 2003. e-Pub 2003. PMID: 12562294.
135. Sun X, Gong Y, Rao MS, Badve S. Loss of BRCA1 expression in sporadic male breast carcinoma. Breast Cancer Res Treat 71:1-7, 2002. e-Pub 2002. PMID: 11859870.
136. Gong Y, Chao J, Bauer B, Sun X, Chou PM. Primary cutaneous alveolar rhabdomyosarcoma of perineum. Arch Pathol Lab Med 126:982-84, 2002. e-Pub 2002. PMID: 12171502.
137. Sun X, Gong Y, Talamonti MS, Rao MS. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in carcinoid tumors. Mod Pathol 15:1333-38, 2002. e-Pub 2002. PMID: 12481015.
138. Gong Y, Kim SO, Grella DK, Castellino FJ, Miles LA. Conversion of glu-plasminogen to lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface. J Biol Chem 276:19078-83, 2001. e-Pub 2001. PMID: 11264290.
139. Parmer RJ, Mahata M, Gong Y, Mahata SK, Jiang Q, O'Connor DT, Xi XP, Miles LA. Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion. J Clin Invest 106:907-15, 2000. e-Pub 2000. PMID: 11018079.
140. Parmer RJ, Mahata SK, Jiang Q, Taupenot L, Gong Y, Mahata M, O'Connor DT, Miles LA. Tissue plasminogen activator and chromaffin cell function. Adv Exp Med Biol 482:179-92, 2000. e-Pub 2000. PMID: 11192579.
141. Gong Y, Xu Y. Effects of cadmium on macrophage-mediated cytotoxicity toward tumor cells. Zhejiang Medical Journal (In Chinese) 13:3-6, 1991. e-Pub 1991.
142. Gong Y. Effects of cadmium on macrophage. J. Environ Health (In Chinese) 6:42-45, 1989. e-Pub 1989.

Invited Articles

1. Yu W, Gan Q, Gong Y. The Yokohama System for Reporting Breast Cytopathology. JCTP 3(2):99-105, 2023. e-Pub 2023.
2. He J, Gong Y. Diagnostic Pitfalls of an Epithelioid Angiosarcoma in Fine-Needle Aspiration Sample. American Society of Clinical Pathology Case Reports. Cytopathol. CY17-6, 2017. e-Pub 2017.
3. Gong Y. Commentary on “Lack of CD151/integrin a3b1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers”. Breast Disease: A Year Book Quarterly 27(2), 2016. e-Pub 2016.
4. Gong Y. Commentary on “Histologic Grade Remains a Prognostic Factor for Breast Cancer Regardless of the Number of Positive Lymph Nodes and Tumor Size--A Study of 161 708 Cases of Breast Cancer From the SEER Program”. Breast Disease: A Year Book Quarterly 26(1), 2015. e-Pub 2015.
5. Gong Y. Commentary on "High TFAP2C/low CD44 expression is associated with an increased rate of pathologic complete response following neoadjuvant chemotherapy in breast cancer". Breast Diseases: A Year Book Quarterly 25(2), 2014. e-Pub 2014.
6. Gong Y. Significance of biomarker discordance in breast cancer from the pathologist's perspective. Cancer Biomarkers 12:207-18, 2013. e-Pub 2013. PMID: 23735941.
7. Gong Y. Commentary on "Accurate and rapid novel genetic diagnosis for detection of sentinel lymph node metastasis in breast cancer patient". Breast Diseases: A Year Book Quarterly 24(1), 2013. e-Pub 2013.
8. Zheng J, Gong Y. Fine needle aspiration of pancreatic lesions: diagnostic features and pitfalls. Chin J Dig Endosc 30:421-23, 2013. e-Pub 2013.
9. Zhang S, Gong Y. From Cytomorphology to Molecular Pathology: Maximizing the Value of Cytology of Lymphoproliferative Disorders and Soft Tissue Tumors. Am J Clin Pathol 140:454-67, 2013. e-Pub 2013. PMID: 24045541.
10. Gong Y. Commentary on "In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival". Breast Diseases: A Year Book Quarterly 23(4), 2012. e-Pub 2012.
11. Gong Y. Commentary on "Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group". Breast Diseases: A Year Book Quarterly 23(3), 2012. e-Pub 2012.
12. Gong Y. Commentary on "Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina breast cancer study". Breast Diseases: A Year Book Quarterly 22(3), 2011. e-Pub 2011.
13. Kundu U, Gong Y. Malignant Mixed Mullerian Tumor with a Lung Metastasis: Fine Needle Aspiration Cytology and Histology Correlation. Pathology Case Reviews 16:90-93, 2011. e-Pub 2011.
14. Cheng Y, Gong Y. Diagnostic pitfalls of an inguinal endometriosis sampled via fine-needle aspiration. Cytopathol 37:113-23, 2009. e-Pub 2009.
15. Gong Y, Xiao C, Fu L. HER2 testing: Current issues and future directions. Chin J Pathol 38:795-99, 2009. e-Pub 2009.
16. Gong Y. Pathology aspect of inflammatory breast cancer: part 2. Biologic insights into its aggressive phenotype. Semin Oncol 35:33-40, 2008. e-Pub 2008. PMID: 18308144.
17. Gong Y, Symmans WF, Pusztai L. Gene expression microarrays provide new prognostic and predictive tests for breast cancer. Pharmacogenomics 8:1359-68, 2007. e-Pub 2007. PMID: 17979510.

Professional Educational Materials

1. . TV Interview: Breast cancer prevention and early detection. Television Station of Zhenjiang Province, China, 2014.
2. . Written Interview invited by MedicalResearch.com: Inflammatory Breast Cancer: Relevance of Androgen Receptor Expression. (http://medicalresearch.com/cancer-_-oncology/breast-cancer/inflammatory_breast_cancer_relevance_of_androgen_receptor_expression/4439), 2014.
3. Gong Y. BIOCARE Medical educational seminar series presented at USCAP 2009, vol. 1 (DVD): Reliability of chromogenic in situ hybridization (CISH) for detecting HER2 gene status in breast carcinoma, 2009.
4. Gong Y. A contributor in a teaching activity to increase awareness of inflammatory breast cancer among healthcare professionals and in the community (DVD): Inflammatory Breast Cancer: Teach it, Treat it, Beat it, 2008.

Abstracts

1. Yu W, Gong Y, Sneige N. Fine-Needle Aspiration of Metastatic Tumors to the Parotid Gland. The 113th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2024. e-Pub 2024.
2. Alexander A, Murphy H, Reuben JM, Le-Petross HT, Lane D, Huang M, Krishnamurthy S, Gong Y, Gombos D, Patel N, Allen RC, Liu S, Patel AB, Futreal A, Wistuba I, Layman R, Ueno NT, Tripathy D, Valero V. Phase II Trial of Combination of Atezolizumab, Cobimetinib and Eribulin (ACE) or Atezolizumab and Eribulin (AE) in patients with metastatic inflammatory breast cancer (IBC): Clinical data of both cohorts. 46th Annual San Antonio Breast Cancer Symposium, 2023. e-Pub 2023.
3. Toomer KH, Tang G, Cheng J, Gong Y, Mamie TS, Zhang H, Zhang B, Chan DW, Li QK. Correlation between HER2 Immunohistochemistry (IHC) Staining Pattern and HER2/neu Copy-Number Amplification in Primary and Metastatic Non-Small Cell Lung Carcinoma (NSCLC): A Study of 232 Cases. The 112th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2023. e-Pub 2023.
4. Guo H, Ding Q, Gong Y, Gilcrease MZ, Zhao M, Zhao J, Sui D, Wu Y, Chen H, Liu H, Zhang J, Moulder S, Wang WL, Huo L. Comparison of Three FDA Approved PD-L1 Immunohistochemistry Assays in Triple Negative Breast Carcinoma-Platform Presentation. The 109th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2020. e-Pub 2020.
5. Assi J, Wang WL, Krishnamurthy S, Gong Y, Stewart J, Gan Q. Immunocytochemical Staining Validation of Nuclear Staining Markers on Cytology Smears. Comparison of Three FDA Approved PD-L1 Immunohistochemistry Assays in Triple Negative Breast Carcinoma. The 109th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2020. e-Pub 2020.
6. Hou T, Gan Q, Joseph C, Sun X, Gong Y. Insulinoma-associated Protein 1 (INSM1) Immunostaining in Various Types of Neuroendocrine Tumors on Fine-Needle Aspiration Smear. The 109th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2020. e-Pub 2020.
7. Zhou T, Gong Y, Gong Z, Medeiros LJ, Hu S. Body Fluid Blast Phase of Chronic Myeloid Leukemia. Poster. The 108th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2019. e-Pub 2019.
8. Wang M, Kundu UR, Gong Y. The Diagnostic Accuracy of Fine-Needle Aspiration (FNA) on Thymic Lesions: A Review of Cytologic Features in Conjunction with Histologic Findings. The 108th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2019. e-Pub 2019.
9. Wang M, Gong Y. Concordance of Ki-67 Proliferative Index in B-Cell Non-Hodgkin Lymphomas between Fine Needle Aspiration and Corresponding Tissue Biopsy Samples. The 108th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2019. e-Pub 2019.
10. Porteus C, Gan Q, Gong Y, Pantanowitz L, Mela N, Henderson-Jackson E, Peterson D, Bui M. Cytology of Sclerosing Epithelioid Fibrosarcoma: Multicenter and Literature Review to Identify Diagnostic Pitfalls. Poster presentation at the ASC's 67th Annual Scientific Meeting, Salt Lake City, Utah. The ASC's 67th Annual Scientific Meeting, 2019. e-Pub 2019.
11. Hu X, Villodre ES, Larson R, Rahal OM, Wang X, Gong Y, Song J, Krishnamurthy S, Ueno NT, Tripathy D, Woodward WA, Debeb BG. Decorin is a critical regulator of tumorigenesis and skin invasion in inflammatory breast cancer by destabilizing E-cadherin-EGFR axis. The 42nd Annual San Antonio Breast Cancer Symposium, 2019. e-Pub 2019.
12. Villodre ES, Hu X, Gong Y, Song J, Larson R, Eckhardt BL, Huo L, Krishnamurthy S, Ibrahim N, Ueno NT, Tripathy D, Woodward WA, Debeb BG. NDRG1-EGFR axis in inflammatory breast cancer tumorigenesis and brain metastasis. Poster presentation at the 42nd Annual San Antonio Breast Cancer Symposium. The 42nd Annual San Antonio Breast Cancer Symposium, 2019. e-Pub 2019.
13. Gan Q, Joseph CT, Guo M, Sun X, Gong Y. NKX3.1 is a Sensitive Marker for Detecting Metastatic Prostatic Carcinoma Except for Small Cell Variant on Fine-Needle Aspiration Smears. The 97th Annual Meeting of the Texas Society of Pathologists, 2018. e-Pub 2018.
14. Gan Q, Joseph CT, Guo M, Sun X, Gong Y. NKX3.1 is a Sensitive Marker for Detecting Metastatic Prostatic Carcinoma Except for Small Cell Variant on Fine-Needle Aspiration Smears. The ASC's 66th Annual Scientific Meeting, 2018. e-Pub 2018.
15. Chen L, He J, Gong Y, Stewart J, Staerkel G, Guo M. Diagnostic Efficacy of Combined Fine Needle Aspiration and Core Needle Biopsy in Patients with Lung Nodules. The 107th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2018. e-Pub 2018.
16. Guo H, Ding Q, Gong Y, Gilcrease MZ, Zhao M, Zhao J, Wu Y, Chen H, Moulder S, Wang WL, Huo L. PD-L1 Expression (clone 28-8) and Tumor Infiltrating Lymphocytes in Primary Invasive Breast Cancer. The 107th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP), 2018. e-Pub 2018.
17. Salazar K, Dawlett M, Sneige N, Gong Y, Staerkel G, Guo M. Performance of Hybrid Capture 2 and Cervista HR HPV Testing Assays for Women with Atypical Squamous Cell of Undetermined Significance Pap Test Results in Cervical Cancer Screening vs. Surveillance Population. The ASC's 66th Annual Scientific Meeting,, 2018. e-Pub 2018.
18. Shen T, Zhao J, Zhao M, Taggart MW, Ramalingam P, Gong Y, Wu Y, Huo L. Unusual Expression of Immunohistochemical Markers PAX8 and CDX2 in Breast Cancer. The 107th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2018. e-Pub 2018.
19. Guo H, Ding Q, Gong Y, Gilcreast MZ, Zhao J, Wu Y, Chen H, Moulder S, Wang WL, Huo L. PD-L1 Expression (clone 22C3) and Tumor Infiltrating Lymphocytes in Primary Invasive Breast Cancer. The 107th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP), 2018. e-Pub 2018.
20. Barkan G, Rossi E, Tabatabai ZL, Abro S, Fadda G, Gan Q, Gong Y, Lose H, Maleki Z, Mehrotra S, Morency E, Naya R, Opera-llies G, Samolczyk J, Smith G, Sun W, Zhao J, Pambuccian S. On The Way To Milan: A Multi-Institutional Study On The Reporting Rates Of Salivary Gland Cytopathology. The 107th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2018. e-Pub 2018.
21. Alexander A, Marx AN, Reddy SM, Reuben JM, Le-Petross HT, Lane D, Huang M, Krishnamurthy S, Gong Y, Gombos D, Patel N, Tung C, Allen RC, Kandl T, Wu J, Liu S, Patel AB, Futreal A, Wistuba I, Layman R, Valero V, Ueno NT, Tripathy D, Lim B. A phase II study of triple combination of atezolizumab, cobimetinib and eribulin (ACE) for patients with recurrent/metastatic inflammatory breast cancer (IBC). The 41st Annual San Antonio Breast Cancer Symposium, 2018. e-Pub 2018.
22. Alouch N, Gong Y, Guo M. Diagnostic Accuracy and Efficacy of Renal Pelvic Washing: Clincal and Pathologic Correlation. The ASC's 65th Annual Scientific Meeting, 2017. e-Pub 2017.
23. He J, Jerz JL, Zhao J, Guo M, Gong Y. Potential factors that could lead to false-positive fine needle aspiration diagnosis. The ASC's 65th Annual Scientific Meeting, 2017. e-Pub 2017.
24. He J, Huo L, Ma J, Zhao J, Bassett RL, Sung X, Ueno N, Gong Y. Expression of programmed death ligand-1 (PD-L1) in inflammatory breast cancers. CAP17 Meeting, 2017. e-Pub 2017.
25. Willey JS, Parker CA, Valero V, Lim B, Reuben JM, Krishnamurthy S, Gong Y, Scoggins ME, Dryden MJ, Liu DD, Woodward WA, Ueno NT. A phase II study of anti-PD-1 (MK-3475) therapy in patients with metastatic inflammatory breast cancer (MIBC) or non-IBC triple negative breast cancer (non-IBC TNBC) who have achieved clinical response or stable disease to prior chemotherapy. The 40th Annual San Antonio Breast Cancer Symposium, 2017. e-Pub 2017.
26. Alexander A, Willey J, Sun J, Parker C, Marx A, Wood A, Reddy SM, Reuben JM, Bassett R, Le-Petross HC, Krishnamurthy S, Gong Y, Woodward W, Valero V, Neno NT, Lim B. A single arm phase II study of adjuvant anti-PD1 (pembrolizumab) in combination with hormonal therapy in patients with hormone receptor (HR)-positive localized inflammatory breast cancer (IBC) who did not achieve a pathological complete response (pCR) to neoadjuvant chemotherapy. The 40th Annual San Antonio Breast Cancer Symposium, 2017. e-Pub 2017.
27. Zhou H, Guo M, Gong Y. Fine needle aspiration diagnosis of angiomyolipoma: a study of 33 cases. the 105th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2016. e-Pub 2016.
28. Leng B, Guo M, Gong Y. Utility and Pitfalls of GATA3 Immunocytochemistry for Diagnosis of Breast and Urothelial Carcinomas in Cytology Specimens. The 105th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2016. e-Pub 2016.
29. Wang H, Hoda R, Faquin W, Rossi ED, Sun T, Hotchandani N, Patel V, Pusztaszeri M, Bizzarro T, Bongiovanni M, Jhala N, Gong Y. Secondary malignancies in salivary glands: A multi-institutional FNA cohort from trans-Atlantic academic institutions. The 105th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2016. e-Pub 2016.
30. Rudzinski JL, Zhao J, Staerkel G, Gong Y. What Amended Fine-Needle Aspiration Reports Tell Us. The ASC's 64th Annual Scientific Meeting, 2016. e-Pub 2016.
31. Zhou H, Bassett R, Khanna A, Dawlett M, Sneige N, Schmeler K, Milbourne A, Bevers T, Gong Y, Staerkel G, Guo M. Population-based HPV Testing Performance: Potential False Negative HPV Results in a Cervical Cancer Surveillance Population. EUROGIN 2016: International Multidisciplinary Congress, 2016. e-Pub 2016.
32. Ruiz-Cordero, Khanna A, Robinson M, Lyons G, Roland B, Stewart J, Gong Y, Staerkel G, Guo M. Fluorescence in-situ Hybridization Testing in Cytology Specimens of Patients with Lung Carcinoma. The ASC's 64th Annual Scientific Meeting, 2016. e-Pub 2016.
33. Sneige N, Gong Y, Multani AS, Hess KR, Ibrahim NK. The Clinical Utility of Alternative Chromosome 17 Probes in Equivocal HER2 Results. The 38th Annual San Antonio Breast Cancer Symposium, 2015. e-Pub 2015.
34. Nelles N, Khanna A, Patel S, Gong Y, Guo M. Predictive value of HPV testing for high-grade cervical and vaginal intraepithelial lesions in patients with mildly abnormal Pap testing results and therapy effects. The 104th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2015. e-Pub 2015.
35. Liang Y, Li X, Wang J, Huo L, Albarracin C, Gong Y, Wu Y. Prognostic significance of multifocal lesion in ER+ breast cancers. The 103rd Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2014. e-Pub 2014.
36. Clevenger J, Joseph C, Dawlett M, Gong Y. Reliability of immunocytochemical staining of SOX10, MITF and pan-melanoma cocktail in confirming melanoma on fine-needle aspiration smears. The 103rd Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2014. e-Pub 2014.
37. Zhang YH, Liu J, Dawlett M, Guo M, Sun X, Gong Y. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples. The 103rd Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2014. e-Pub 2014.
38. Singh C, Kundu UR, Gong Y, Landon G. Cytomorphology of metastatic angiosarcoma in effusions. the 62nd Annual Scientific meeting of American Society of Cytopathology (ASC), 2014. e-Pub 2014.
39. Kundu U, Landon G, Gong Y. Diagnostic dilemmas in identifying thymic lesions via fine-needle aspiration (FNA) samples: a review of cytologic features in conjunction with histologic and clinical findings. The 62nd Annual Scientific Meeting of American Society of Cytopathology (ASC), 2014. e-Pub 2014.
40. Khanna A, Patel S, Gong Y, Staerkel GA, Guo M. The efficacy of HPV16/18 genotyping in predicting CIN2+ in women with HPV+/Pap-results-Platform Presentation. The 62nd Annual Scientific Meeting of American Society of Cytopathology (ASC, 2014. e-Pub 2014.
41. Alexander A, Karakas C, Gong Y, Alvarez R, Ueno NT, Keyomarsi K. Targeting deregulated cyclin E in inflammatory breast cancer via sequential combination therapy. The 36th Annual San Antonio Breast Cancer Symposium, 2013. e-Pub 2013.
42. Gong Y, Wei W, Wu Y, Huo L. Expression of Androgen Receptor in Triple-Negative Breast Carcinomas and Inflammatory Breast Carcinomas. The 102nd Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2013. e-Pub 2013.
43. Liu H, Shi J, Prichard J, Gong Y, Lin F. Immunohistochemical evaluation of GATA-3 expression in ER-negative breast carcinomas. The 102nd Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2013. e-Pub 2013.
44. Gong Y, Chen J, Wang J, Radvanyi L, Rosen DG, Wu Y. Expression of Enhancer of Zeste Homolog 2 (EZH2) in Invasive Neuroendocrine Carcinoma of the Breast. The102nd Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2013. e-Pub 2013.
45. Alexander A, Karakas C, Gong Y, Ueno NT, Keyomarsi K. Novel therapeutic targets in inflammatory breast cancer: Can we target the cell cycle?. Presented at Cancer Prevention & Research Institute of Texas (CPRIT) on Innovations in Cancer Prevention & Research Conference, 2012. e-Pub 2012.
46. Krishna SG, Fleming JB, Ross WA, Bhutani MS, Foo WC, Gong Y, Raju GS, Lee JH. Non-ampullary duodenal carcinoids: Role of endosonography (EUS) and outcome of endoscopic mucosal resection. (EMR)Digestive Disease Week, 2012. e-Pub 2012.
47. Guo M, Dhillon J, Khanna A, Katz R, Gong Y, Staerkel G. Cervista HPV HR and HPV 16/18 assays in head and neck FNA specimens, a valid option of HPV testing, compared with HPV in situ hybridization/p16 immunostaining always in tissue specimens from patients with oropharyngeal carcinoma. The 60th annual Scientific Meeting of American Society of Cytopathology (ASC), 2012. e-Pub 2012.
48. Arun B, Gong Y, Liu D, Litton J, Gutierrez Barrera AM, Sajan B, Lee JJ, Vornik L, Cornelison T, Hortobagyi GN, Lippman S, Brown P, Sneige N. Phase I prevention study of Atorvastatin in women at increased risk for breast cancer. The 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research, 2012. e-Pub 2012.
49. Alvarez RH, Cristofanilli M, Ensor J, Lucci A, Yang W, Le-Petross H, Reuben JM, Babiera G, Huo L, Gong Y, Woodward W, Parker CA, Willey JS, Buchholz TA, Ueno NT, Valero V, Mcnaughton BS. Limited efficacy and significant toxicities of lapatinib (Lap) plus chemotherapy as neoadjuvant therapy (NAC) for HER2-positive inflammatory breast cancer (IBC) patients. 2012 ASCO Conference, 2012. e-Pub 2012.
50. Wang J, Guo M, Gong Y. Fine needle aspiration of lymphoma with signet ring features. The 60th Annual Scientific Meeting of American Society of Cytopathology (ASC), 2012. e-Pub 2012.
51. Gong Y, Chen J, Radvanyi L, Rosen DG, Wu Y. Expression of Enhancer of Zeste homolog 2 (EZH2) in Invasive Neuroendocrine Carcinoma of the Breast. The XXIX International Congress of the International Academy of Pathology (IAP), 2012. e-Pub 2012.
52. Symmans WF, Andreopoulou E, Booser D, Hatzis C, Wallace M, Zhang Y, Gong Y, Ignatiadis M, Sotiriou C, Andre F, Peintinger F, Regitnig P, Marth C, Desmedt C, Loi S, Moulder S, Hortobagyi GN, Pusztai L, Valero V. Progression of genomic signatures in local metastatic estrogen receptor-positive (ER+) breast cancer: relevance to palliative treatment. 2012 ASCO Conference, 2012. e-Pub 2012.
53. Wang X, Saso H, Iwamoto T, Pusztai L, Gong Y, Woodward WA, Reuben JM, Hortobagyi GN, Ueno NT. A Novel Inflammatory Breast Cancer-Specific Oncogene, Tazarotene-Induced Gene 1, Promotes Tumorigenicity and Invasiveness through the Receptor Tyrosine Kinase Axl. The 34th Annual San Antonio Breast Cancer Symposium, 2011. e-Pub 2011.
54. Guo M, Si Q, Gong Y, Kalhor N, Chen S, Moran C. EGFR mutations are closely associated with TTF-1 positive lung adenocarcinoma. The 100th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2011. e-Pub 2011.
55. Zhao L, Sneige N, Gong Y. Value of PAX8 and WT1 immunostains for detecting metastatic ovarian carcinoma in effusion specimens. The 100th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2011. e-Pub 2011.
56. Ma H, Mallampati S, Sun B, Gong Y, Lefebvre V, Sun X. Sox4 is essential for initiation and progression of acute lymphoblastic leukemia induced by p190-BCR-ABL transformation-Platform presentation. the 53rd Annual Meeting of American Society of Hematology (ASH), 2011. e-Pub 2011.
57. Sun B, Mallampati S, Gong Y, Wang D, Lefebvre V, Sun X. Conditional knockout of Sox4 markedly affects early B lymphopoiesis in adult mice-Platform presentation at the 53rd Annual Meeting of American Society of Hematology (ASH), San Diego, CA. The 53rd Annual Meeting of American Society of Hematology (ASH), 2011. e-Pub 2011.
58. Thomison J, Malpica A, Gong Y, Silva E, Sneige N. Peritoneal washing cytology of ovarian tumors of low malignant potential: correlation with invasive versus non-invasive implants and prognosis. The 59th Annual Scientific Meeting of American Society of Cytopathology (ASC), 2011. e-Pub 2011.
59. Kundu U, Gong Y. Sclerosing adenosis of the breast: a retrospective study of fine-needle aspiration features and correlation with corresponding core-needle biopsy features. The 59th Annual Scientific Meeting of American Society of Cytopathology (ASC), 2011. e-Pub 2011.
60. Landon G, Si Q, Guo M, Sneige N, Gong Y. Atypical epithelial cells in fine-needle aspiration biopsy of breast lesions: histologic follow-up and sources of equivocal cytologic diagnosis. The 59th Annual Scientific Meeting of American Society of Cytopathology (ASC), 2011. e-Pub 2011.
61. Niikura N, Liu J, Hayashi N, Mittendorf EA, Gong Y, Palla SL, Tokuda Y, Gonzalez-Angulo AM, Hortobagyi GN, Ueno NT. Clinical significance of metastatic-tumor HER2 status in patients with HER2-positive primary breast cancer. 2011 ASCO Meeting, 2011. e-Pub 2011.
62. Li J, Gonzalez-Angulo AM, Allen PK, Yu TK, Woodward WA, Ueno NT, Lucci A, Krishnamurthy S, Gong Y, Bondy ML, Yang W, Willey JS, Cristofanilli M, Valero V, Buchholz TA. Improved survival outcome in patients with inflammatory breast cancer after establishment of a designated IBC clinic. The 93rd annual meeting of the American Radium Society, 2011. e-Pub 2011.
63. Atiq M, Bhutani M, Ross W, Gong Y, Shah CP, Javle M, Raju GS, Lee JH. Utility of endoscopic ultrasound guided-FNA (EUS-FNA) for diagnosis of metastatic lesions to the pancreas. The Digestive Disease Week, 2011. e-Pub 2011.
64. Wang J, Liu P, Gong Y. Expression of two stem cell markers (ALDH1 and Notch1) in inflammatory breast carcinoma. The 100th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2011. e-Pub 2011.
65. Zhao Q, Rashid A, Gong Y, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PWT, Abdalla EK, Vauthey J, Wang H, Gomez HF, Fleming JB, Abbruzzese JL, Wang H. Complete pathologic response is associated with good prognosis in patients with pancreatic ductal adenocarcinoma who received neoadjuvant chemoradiation followed by pancreatectomy. The 100th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2011. e-Pub 2011.
66. Guo M, Wang J, Dawlett M, Patel S, Liu P, Gong Y, Bevers T, Sneige N. Risk Profiling Using HPV Genotyping in Women with Mildly Abnormal Pap Results-Platform Presentation. The 59th Annual Scientific Meeting of American Society of Cytopathology (ASC), 2011. e-Pub 2011.
67. Wang X, Saso H, Iwamoto T, Pusztai L, Gong Y, Hortobagyi GN, Ueno NT. Tazarotene-induced Gene 1 (TIG1) is a Novel Tumorigenic Gene of Inflammatory Breast Cancer. The 33rd Annual San Antonio Breast Cancer Symposium, 2010. e-Pub 2010.
68. Symmans WF, Hatzis C, Valero V, Booser DJ, Esserman L, Martin M, Vidaurre T, Holmes F, Souchon EA, Lluch A, Cotrina J, Gomez H, Hubbard R, Ferrer-Lozano J, Dyer R, Buxton M, Gong Y, Wu Y, Ibrahim N, Andreopoulou E, Ueno NT, Hunt K, Yang W, Nazario A, DeMichele A, O'Shaughnessy J, Hortobagyi GN, Pusztai L. A genomic predictor of survival following Taxane-Anthracycline chemotherapy for breast cancer. The 33rd Annual San Antonio Breast Cancer Symposium, 2010. e-Pub 2010.
69. Xiao L, Gong Y, Wang Y, Troncoso P, Czerniak BA, Guo CC. The TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate. The 99th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2010. e-Pub 2010.
70. Gong Y, Huo L, Sneige N, Cristofanilli M. Positive EZH2 expression predicts shorter overall survival in patients with inflammatory breast cancer. The 99th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2010. e-Pub 2010.
71. Winston EL, Le-Petross HT, Cristofanilli M, Gong Y, Yang WT. Inflammatory Breast Carcinoma (IBC): Imaging Findings on Mammography, US, MRI, and PET/CT- Educational Electronic Exhibit. The 110th annual meeting of the American Roentgen Ray Society 194:A100-115 (#E0281), 2010. e-Pub 2010.
72. Gong Y. Reliability of Chromogenic in Situ Hybridization (CISH) for Detecting Her2 Gene Status in Breast Carcinoma: A Multicenter Study Using Conventional Scoring Criteria and the New ASCO/CAP Recommendations. The BIT's 3rd World Cancer Congress-Breast Cancer Conference: Fighting Breast Cancer at Molecular Level,, 2010. e-Pub 2010.
73. Billah S, Stewart J, Staerkel G, Gong Y, Guo M. EGFR and KRAS Mutations in Cytology Specimens from Patients with Lung Carcinoma-Platform presentation. The 58th Annual Scientific Meeting of American Society of Cytopathology (ASC), 2010. e-Pub 2010.
74. Arias-Pulido H, Chaher N, Gong Y, Lomo L, Terki N, Qualls C, Bouzid K, Verschraegen C, Royce M. The VEGF-A, -R1 and -R2 expression in inflammatory breast cancer. The 2nd International Inflammatory Breast Cancer Conference, 2010. e-Pub 2010.
75. Pusztai L, Jeong J, Gong Y, Ross J, Kim C, Hortobagyi GN, Paik S, Symmans WF. Evaluation of Microtubule Associated Protein-Tau expression as prognostic and predictive marker in the NSABP B-28 randomized clinical trial-Platform presentation. The 31st Annual San Antonio Breast Cancer Symposium, 2009. e-Pub 2009.
76. Le-Petross HT, Cristofanilli M, Qing Y, Jackson EF, Gong Y, Reed B, Hortobagyi GN, Yang WT. Inflammatory breast cancer: defining magnetic resonance imaging (MRI) features. The 31st Annual San Antonio Breast Cancer Symposium Cancer Res 69 (Suppl.):259S (#4008), 2009. e-Pub 2009.
77. Gong Y, Han H, Xiao C, Gonzalez-Angulo AM, Sneige N. Stability of estrogen receptor and HER2 status following trastuzumab and polychemotherapy regimen. The 32nd Annual San Antonio Breast Cancer Symposium, 2009. e-Pub 2009.
78. Gong Y, Sweet W, Duh Y, Greenfield L, Tarco E, Trivedai S, Symmans WF, Isola J, Sneige N. Impact of chromosome 17 polysomy and equivocal immunostaining results on the HER-2 status determined by chromogenic in situ hybridization (CISH): a study of two institutions using manufacturers' scoring criteria and the new ASCO/CAP recommendations. The 98th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2009. e-Pub 2009.
79. Gong Y, Sweet W, Duh Y, Greenfield L, Zhao L, Tarco E, Symmans WF, Isola J, Sneige N. Reliability of chromogenic in situ hybridization (CISH) for detecting HER-2 gene status in breast cancer: a study of two institutions using manufacturers' scoring criteria and the new ASCO/CAP recommendations. The 98th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2009. e-Pub 2009.
80. Han E, Sneige N, Gong Y. Quantitative Comparison of Estrogen Receptor Status Between Primary Breast Carcinomas and Paired Metastatic Tumors-Platform presentation. The 57th Annual Scientific Meeting of American Society of Cytopathology (ASC), 2009. e-Pub 2009.
81. Han EY, Sneige N, Gong Y. Estrogen receptor status is generally stable during disease progression from primary to metastatic breast cancer. The 98th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 2009. e-Pub 2009.
82. Dawlett M, Wang J, Patel S, Gong Y, Bevers T, Sneige N, Guo M. Co-screening Women 30 Years of Age and Older Using Hybrid Capture® 2 HDNA Testing and Pap Cytology: 2-year Experience in a Cancer Prevention Center-Platform presentation. The 57th Annual Scientific Meeting of American Society of Cytopathology (ASC), 2009. e-Pub 2009.
83. Gong Y, Sweet W Duh YJ, Greenfield L Fang Y, Zhao J, Tarco E, Symmans WF, Isola J, Sneige N. Chromogenic in situ hybridization (CISH) is a reliable method for detecting HER-2 gene status in breast cancer: A multicenter study comparing three methods. The 97th Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 21:33A (#140), 2008. e-Pub 2008.
84. Shaye AN, Gong Y, Yan K, Sneige N, Esteva FJ, Hortobagyi GN, Pusztai L, Symmans WF. Application of the ASCO/CAP guidelines for HER-2 testing to mRNA expression values for microarrays-Platform presentation. The 97th Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 21:54A (#239), 2008. e-Pub 2008.
85. Khalifeh I, Yan K, Pusztai L, Gong Y, Sneige N, Esteva F, Symmans WF. Comparison of prediction results from single gene expression and multigene signatures in matched clinical fine-needle aspiration (FNA) and core biopsy (CBX) samples from patients with breast cancer-Platform presentation. The 97th Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 21:77A (#345), 2008. e-Pub 2008.
86. Gong Y, Sweet W, Duh YJ, Greenfield L, Symmans WF, Isola J, Sneige N. Impact of chromosome 17/HER-2 polysomy on reliability of chromogenic in situ hybridization (CISH): a study of two institutions. The 97th Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 21:33A (#138), 2008. e-Pub 2008.
87. Gong Y, Sweet W, Duh YJ, Greenfield L, Trivedi S, Symmans WF, Isola J, Sneige N. Effect of immunohistochemistry (IHC)-equivocal breast carcinomas on performance of chromogenic in situ hybridization (CISH) and inter-site reproducibility. The 97th Annual Meeting of United States and Canadian Academy of Pathology (USCAP), 21:33A (#139), 2008. e-Pub 2008.
88. Hatzis C, Symmans WF, Lin F, Zheng B, Yan K, Booser DJ, Gong Y, Valero V, Hortobagyi GN, Pusztai L. Genomic predictors of pathologic response to preoperative chemotherapy for triple-negative and ER-positive/HER2-negative breast cancers, 2008. e-Pub 2008.
89. Gong Y. Development of prognostic and predictive variables in breast cancer: personalized approach using gene expression profiling microarray-Platform presentation/invited speaker. EHRLICH II, the 2nd World Conference on Magic Bullets Abstract (#364), 2008. e-Pub 2008.
90. Gong Y, Yan K, Lin F, Anderson K, Sotiriou C, Andre F, Holmes FA, Valero V, Booser D, Pippen JE, Vukelja S, Gomez H, Mejial J, Barajas LJ, Hess KR, Sneige N, Hortobagyi GN, Pusztai L, Symmans WF. A personalized approach to determine prognostic and predictive indicators in breast cancer with gene expression profiling microarray-Platform presentation/invited speaker. The 8th International Conference of Anticancer Research Anticancer Res 28: 3297-98 (#234), 2008. e-Pub 2008.
91. Mallampati S, Sun B, Gong Y, Wang E, You MJ, Amin HM, Ma Y, Shen H, Zweidler-McKay P, Jones D, Yin C, Glassman A, Hagop M, Kantarjian HM, Arlinghaus RB, Sun X. Rooting into the soil, a model for the role of Sox4 in leukemia. The 50th Annual Meeting of American Society of Hematology (ASH), 2008. e-Pub 2008.
92. Sun B, Mallampati S, Wang D, Lefebvre V, You MJ, Amin H, Ma Y, Rajewsky K, Gong Y, Sun X. Conditional knockout of Sox4 markedly affects lymphopoiesis in adult mice. The 50th Annual Meeting of American Society of Hematology (ASH), 2008. e-Pub 2008.
93. Arias-Pulido H, Gong Y, Joste N, Lomo L, Lee S, Verschraegen C, Lara J, Royce M, Prossnitz E, Cristofanilli M. Expression and prognostic significance of EGFR, ER, PR, HER-2 and GPR30 in inflammatory breast cancer. 1st International Inflammatory Breast Cancer Conference, 2008. e-Pub 2008.
94. Le-Petross HT, Cristofanilli M, Reed B, Harrell R, Babiera G, Gong Y, Jackson EF, Hortobagyi GN, Yang WT. Inflammatory breast cancer: defining magnetic resonance imaging (MRI) features at 1.5 and 3.0 T. The 1st International Inflammatory Breast Cancer Conference, 2008. e-Pub 2008.
95. Gong Y. Prognostic and predictive variables in breast cancer: personalized approach using gene expression profiling microarray-Platform presentation/invited speaker. BIT's Life Sciences' 1st Annual World Cancer Congress, Theme: From Basic Research to Therapeutics, Overseas Scholar Entrepreneur Association, 2008. e-Pub 2008.
96. Dawood S, Gonzalez-Angulo AM, Broglio K, Gong Y, Resetkova E, Yang WT, Barnett CM, Islam R, Ueno NT, Hortobagyi GN, Cristofanilli M. HER-2 positive inflammatory breast cancer: high pathological response rate with trastuzumab-based neoadjuvant therapy. The 30th Annual San Antonio Breast Cancer Symposium Breast Cancer Res Treat 106 (S1):4060A, 2007. e-Pub 2007.
97. Guo M, Sneige N, Gong Y, Deavers M, Silva E, Jan YJ, Zhang W, Cogdell D, Lin E, Luthra R. Comparison of INFORM HPV in situ hybridization with PCR assay for detection of human papilloma virus (HPV) in cervical carcinoma and cervical intraepithelial neoplasia. The 96th Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 20:908A, 2007. e-Pub 2007.
98. Nicolas M, Gong Y. Fine-needle aspiration cytology of primary and metastatic papillary renal cell carcinoma: a study of 45 cases. The 96th Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 20:338A, 2007. e-Pub 2007.
99. Payne M, Staerkel G, Gong Y. Indeterminate diagnosis in fine-needle aspiration of the pancreas: reasons and clinical implications. The 96th Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 20:344A, 2007. e-Pub 2007.
100. Piao Y, Guo M, Gong Y. Fine-needle aspiration cytology of metastatic spindle cell melanoma: a study of 81 cases. The 96th Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 20:346A, 2007. e-Pub 2007.
101. Warrich I, Mutyama B, Patel S, Cogdell D, Zhang W, Lin E, Gong Y, Sneige N, Guo M. HPV DNA testing with selected HPV genotyping is more efficient than p16 immunostaining in predicting high-grade cervical intraepithelial neoplasia in women with atypical squamous cells of undetermined significance (ASC-US)-Platform presentation. The 55th Annual Scientific Meeting of American Society of Cytopathology (ASC) Cancer Cytopathol 111:348 (PF5), 2007. e-Pub 2007.
102. Sun X, Irvin N, Han X, Ginsberg CFH, Gong Y. A novel type of inclusion in peripheral blood neutrophils. The Annual Meeting of American Society for Clinical Pathology (ASCP), 2007. e-Pub 2007.
103. Guo M, Gong Y, Dawlett M, Patel S, Bevers T, Sneige N. HPV DNA co-screening with Pap cytology in women 30 years old and older in a cancer prevention center. The 55th Annual Scientific Meeting of American Society of Cytopathology (ASC) Cancer Cytopathol 111:386 (54A), 2007. e-Pub 2007.
104. Ge Y, Sneige N, Eltorky MA, Gong Y, Guo M. Immunohistochemical characterization of subtypes of male breast carcinoma. The 95th Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 19:27A, 2006. e-Pub 2006.
105. Lin H, Anderson K, Rouzier R, Gong Y, Pusztai L, Symmans WF, Arlinghaus R, Wu Y. Neutrophil Galatinase-associated lipocalin (NGAL) is highly associated with HER2+/ER- breast cancers and is a downstream effector of P13/AKT pathway. The 95th Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 19:33A, 2006. e-Pub 2006.
106. Sun X, Wang E, Zuo C, Jones D, Gong Y, Ai L, Glassman A, Ginsberg C, Kantarjaina H, Fan C. Expression of the DNA excision repair gene OGG1 in chronic myeloproliferative disorder and acute myeloid leukemia. The 95th Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 19:247A, 2006. e-Pub 2006.
107. Ren R, Gong Y. Fine-needle aspiration of adrenal cortical carcinoma: morphologic spectrum and diagnostic challenges. Poster presentation at XXVI International Congress of the International Academy of Pathology (IAP), Montreal, Quebec. XXVI International Congress of the International Academy of Pathology (IAP) 19:37A, 2006. e-Pub 2006.
108. Arun B, Valero V, Yin G, Babiera G, Murray JL, Browne D, Gong Y, Cook E, Hortobagyi GN, Sneige N. Phase II breast cancer chemoprevention study with celecoxib in women at increased risk for breast cancer J Clin Oncol 24:18S (#1010), 2006. e-Pub 2006.
109. Gong Y, Gonzalez-Angulo AM, Broglio K, Huo L, Sneige N, Cen P, Woodard W, Valero V, Hunt KK, Buchholz TA, Hortobagyi GN, Cristofanilli M. Expression of Notch-1 and 946;-catenin: defining the molecular portrait of inflammatory breast cancer. the 29th Annual San Antonio Breast Cancer Symposium Breast Cancer Res Treat 100 (S1):299 (#6131), 2006. e-Pub 2006.
110. Sneige N, Gong Y, Lammey J, Valero V, Babiera G, Kuerer H, Hortobagyi G, Arun B. Baseline proliferation markers and cytopathologic findings in breast epithelium of women at increased risk for breast cancer. The 28th Annual San Antonio Breast Cancer Symposium 23:884 (#9694), 2005. e-Pub 2005.
111. Symmans WF, Sotiriou C, Anderson K, Hatzis SK, Valero V, Booser D, Larsimont D, Desmedt C, Gold DL, Sneige N, Cristofanilli M, Arun B, Gong Y, Hess K, Ross JS, Piccart M, Hortobagyi GN, Pusztai L. Measurements of estrogen receptor and reporter genes from microarrays determine receptor status and time to recurrence following adjuvant tamoxifen therapy. The 28th Annual San Antonio Breast Cancer Symposium Breast Cancer Res Treat 94 (S1):32 (#308), 2005. e-Pub 2005.
112. Gong Y, Sneige N, Hicks ME, Moran CA. Percutaneous fine needle aspiration and concurrent core needle biopsy of pulmonary lesions: A retrospective comparison of 362 patients. The 94th Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 18:311A, 2005. e-Pub 2005.
113. Arun B, Valero V, Hornbeak J, Gong Y, Broglio K, Logan C, Browne D, Hortobagyi G, Sneige N. Celecoxib downregulates estrogen receptor expression in breast tissue of women at increased risk for developing breast cancer. The 28th Annual San Antonio Breast Cancer Symposium/Breast Cancer Res Treat 94:(S1):S169 (#4013), 2005. e-Pub 2005.
114. Guo M, Jan YJ, Gong Y, Sneige N. Clinical utility of immunostains in the differential diagnosis of lung malignancies by FNA lung biopsies. Poster presentation at the 53rd Annual Scientific Meeting of American Society of Cytopathology (ASC), San Diego, CA. The 53rd Annual Scientific Meeting of American Society of Cytopathology (ASC, 2005. e-Pub 2005.
115. Cabioglu N, Gong Y, Sneige N, Sahin A, Gonzalez-Angulo AM, Bucana C, Morandi P, Hortobagyi G, Cristofanilli M. Increased expression of chemokine receptors in inflammatory breast cancer: implications for novel targeted therapies. The Annual Meeting of American Society of Clinical Oncologist (ASCO) 23(Suppl):9655, 2005. e-Pub 2005.
116. Gonzalez-Angulo AM, Guarneri V, Gong Y, Morales-Vasquez F, Cristofanilli M, Hortobagyi GN. P27 deregulation as a prognosis marker inflammatory breast cancer. The European Cancer Conference, 2005. e-Pub 2005.
117. Gong Y, Tarco E, Sneige N. Comparison of HER-2 status determined by Fluorescence In Situ hybridization (FISH) in primary and metastatic breast cancer. The 93rd Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 17:68A, 2004. e-Pub 2004.
118. Gong Y, Diaz L, Wiley E, Sneige N. Comparison of Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH) in the evaluation of HER-2 status. The 93rd Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 17:32A, 2004. e-Pub 2004.
119. Joseph T, Sneige N, Gong Y. Validation of commonly used immunostaining results on cell transferred cytologic specimens. Poster presentation at the 52nd Annual Scientific Meeting of American Society of Cytopathology (ASC), Chicago, IL. The 52nd Annual Scientific Meeting of American Society of Cytopathology (ASC), 2004. e-Pub 2004.
120. Jacob B, Desai J, Gong Y. The significance of atypical squamous cells of undetermined significance (ASCUS) and atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion (ASC-H) in gynecologic specimens of a cancer institution. The 52nd Annual Scientific Meeting of American Society of Cytopathology (ASC), 2004. e-Pub 2004.
121. Gong Y, Gu J, Caraway NP, Zaidi T, Sun X, Fernandez R, Katz RL. Evaluation of fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation with flow cytometry in the diagnosis of follicular lymphoma on fine needle aspirates (FNAs). The 92nd Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 16:65A, 2003. e-Pub 2003.
122. Sun W, Recine MA, Gong Y, Staerkel G. Comparison of endoscopic ultrasound-guided and CT-guided fine needle aspiration biopsy in the diagnosis of pancreatic lesions. The 92nd Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 16:83A, 2003. e-Pub 2003.
123. Recine MA, Gong Y, Sun W, Kaw M, Evans D, Sneige N, Krishnamurthy S. Fine needle aspiration cytology of mucinous tumors of the pancreas. The 92nd Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 16:79A, 2003. e-Pub 2003.
124. Gong Y, Recine M, Sun W, Sneige N. Intraductal papillary mucinous neoplasms of the pancreas - features and biomarker findings of 14 cases. The 51st Annual Scientific Meeting of American Society of Cytopathology (ASC), 2003. e-Pub 2003.
125. Sun W, Recine M, Gong Y, Staerkel G. Source of false negative and inconclusive diagnoses in fine needle aspiration (FNA) biopsies of pancreatic lesions. The 51st Annual Scientific Meeting of American Society of Cytopathology (ASC), 2003. e-Pub 2003.
126. Gong Y, Symmans FW, Krishnamurthy S, Patel S, Sneige N. Optimal fixation condition for immunocytochemical analysis of estrogen receptor in cytology specimens of breast cancer. The 92nd Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 16:66A, 2003. e-Pub 2003.
127. Sun W, Gong Y, Recine M, Staerkel G. Fine Needle Aspiration (FNA) biopsy of pancreatic metastases. The 51st annual Scientific Meeting of American Society of Cytopathology (ASC), 2003. e-Pub 2003.
128. Gong Y, Attal S, Sun X, Bedrossian CWM. A simple panel of immunocytochemistry markers in detecting adenocarcinoma in serous effusion-a cost effective and reliable approach. The 91st Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 15:74A, 2002. e-Pub 2002.
129. Gong Y, Sun X, Attal S, Bedrossian CWM. Immunocytochemistry on serous effusion specimens: a comparison of ThinPrep versus cell blocks. The 91st Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 15:73A, 2002. e-Pub 2002.
130. Weinrach D, Gong Y, Sun X, Wiley EL, Rao MS. Immunohistochemical evaluation of CA-125 expression in tubular and micropapillary carcinomas of the breast. The 91st Annual Meeting United States and Canadian Academy of Pathology (USCAP) 15:56A, 2002. e-Pub 2002.
131. Sun X, Gong Y, Hussong JW, Goolsby CL, Variakojis D. CD10 positive polyclonal B cells in lymph node biopsy are associated with heterogeneous clinical presentations. The 91st Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 15:265A, 2002. e-Pub 2002.
132. Patton K, Sun X, Gong Y, Wiley EL, Rao MS. Expression of cell cycle regulators P21, P27, Cyclin D1 and P53 in infiltrating micropapillary and tubular carcinomas of the breast. the 91st Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 15:46A, 2002. e-Pub 2002.
133. Chen YH, Gupta A, Huo L, Gong Y, Tan XD, Rao MS. Expression of trefoil factors (TFF1 and TFF3) in Barrett's esophagus dysplasia and adenocarcinoma arising in Barrett's disease. The 91st Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 15:124A, 2002. e-Pub 2002.
134. Gong Y, Sun X, Wiley EL, Rao MS. Expression of cell adhesion molecules, CD44s and E-cadherin, in infiltrating micropapillary versus tubular carcinomas of the breast. The 24th Annual San Antonio Breast Cancer Symposium 29:295, 2001. e-Pub 2001.
135. Sun X, Gong Y, Wiley EL, Rao MS. Microvessel density is higher in invasive micropapillary carcinoma than in tubular carcinoma of the breast. The 24th Annual San Antonio Breast Cancer Symposium 29:294, 2001. e-Pub 2001.
136. Sun X, Gong Y, Rao S. Loss of CD44s expression is associated with metastatic potential of carcinoid tumor. The 90th Annual Meeting of United States and Canadian Academy of Pathology (USCAP 14:78A, 2001. e-Pub 2001.
137. Gong Y, Sun X, Rao S. Tumor angiogenesis in carcinoid tumors. The 90th Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 14:220A, 2001. e-Pub 2001.
138. Gong Y, Sun X, Sweet A, Binder LI, Berry R, Ghoshal N, Quinn B. The range of novel Tau pathologies: systematic studies of visualization factors. The 90th Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 14:207A, 2001. e-Pub 2001.
139. Miles L, Green M, Gong Y, Jardi M, Felez J. Monoclonal antibodies detect receptor-induced binding sites (ribs) in plasminogen induced by its interaction with cells-Platform presentation. The 15th International Congress on Fibrinolysis and Proteolysis 14 (Suppl. 1), 2000. e-Pub 2000.
140. Sun X, Gong Y, Yeldandi A, Rao S, Badve S. Neuroendocrine differentiation in male breast carcinoma. Poster presentation the 51st Annual Meeting of the Histochemical Society, New Orleans, LA. The 51st Annual Meeting of the Histochemical Society, 2000. e-Pub 2000.
141. Gong Y, Sun X, Okonkwo A, Benson A, Rao S, Badve S. High frequency of thymidylate synthase expression in male breast carcinomas. The 89th Annual Meeting of United States and Canadian Academy of Pathology (USCAP) 13:22A, 2000. e-Pub 2000.
142. Sun X, Gong Y, Yeldandi A, Rao S, Badve S. Prostate markers in male breast carcinoma. The 51st Annual Meeting of the Histochemical Society, 2000. e-Pub 2000.
143. Sun X, Gong Y, Rao S, Badve S. Loss of BRCA1 expression in sporadic male breast carcinoma. Poster presentation at the 51st Annual Meeting of the Histochemical Society, New Orleans, LA. The 51st Annual Meeting of the Histochemical Society, 2000. e-Pub 2000.
144. Parma RJ, Gong Y, Jiang Q, Miles L. A potential mechanism for the trafficking of tissue plasminogen activator (t-pa) to the regulated pathway of secretion: binding to the major secretory vesicle protein, chromogranin a (cga) 11 (Suppl. 3), 1997. e-Pub 1997.
145. Liu JM, Gong Y, Sun X, Shi A, Han X, Liu J, Huang P, Subash KM, Wang WJ, Chen E, Medeiros LJ, Wang W, Wu J, Hu Z. Quantitative assessment of Disease Status in Chronic Lymphocytic Leukemia Using Artificial Intelligence (AI)-Assisted Peripheral Blood Smear Image Analysis. 114th Annual Meeting of United States and Canadian Academy of Pathology (USCAP).
146. Chen H, Gong Y, Kai M, Huo L, Woodward W. Variation of CCR7 Immune Cell Receptor Expression by Nodal Burden in Patients with Invasive Breast Cancer. 47th Annual San Antonio Breast Cancer Symposium.
147. Hu X, Rizzo IL, Villodre EX, Phi THL, Tesfamariam KH, Song J, Gong Y, Krishnamurthy S, Woodward WA, Debeb BG. Therapeutic Inhibition of the sEcad–PDIA4 Axis Suppresses Brain Metastasis in Inflammatory Breast Cancer. 48th Annual San Antonio Breast Cancer Symposium.
148. Tesfamariam KH, Hu X, Longa I, Villodre E, Phi LTH, Song J, Krishnamurthy S, Gong Y, Priebe W, Woodward W, Debeb BG. sEcad–STAT3/NFκB axis in inflammatory breast cancer progression. 48th Annual San Antonio Breast Cancer Symposium.
149. Ibrahim E, Gong Y, Krishnamurthy S, Meis JM, Yu W. Metastatic Sarcomas to Pleural Effusion: A Referral Cancer Center Experience. 114th Annual Meeting of United States and Canadian Academy of Pathology (USCAP).

Book Chapters

1. Rossi ED, Field AS, Ali SZ, Chandra A, Gong Y, Maleki Z, Ping B, Wang H. Chapter 6: Suspicious for Malignancy. In: The Milan System for Reporting Salivary Gland Cytopathology 2nd Edition. 2nd. Springer, 2023.
2. Gong Y. Chapter 15: Cytopathology of the Pancreas. In: Practical Pancreas and Biliary Tract Pathology - Frequently Asked Questions. Springer, 2021.
3. He J, Gong Y. Cytology Techniques. In: Practical Cytopathology-Frequently Asked Questions. Springer, 2019.
4. Jing H, Arabzadeh E, Gong Y, Wang H. Chapter 5: Salivary Gland FNA. In: Practical Cytology- Frequently asked questions. Springer Science and Business Media, 19106, 2019.
5. Rossi ED, Field AS, Ali SZ, Chandra A, Gong Y, Maleki Z, Ping B, Wang H. Chapter 6: Suspicious for Malignancy 1st Edition. In: The Milan System for Reporting Salivary Gland Cytopathology. Springer, 2018.
6. Wang H, Malik A, Gong Y. Chapter 1: Salivary Gland Fine Needle Aspiration. In: Atlas of Non-Gynecologic Cytology. Springer, 1-19, 2018.
7. Gong Y. Molecular study of breast cancer in cytology samples. In: Molecular Cytopathology. Springer, 2016.
8. Zhang X, Huang Y, Gong Y. Fine-needle aspiration of liver lesions. In: Fine Needle Aspiration Cytopathology (In Chinese). Beijing Scientific Publisher, 216-46, 2014.
9. Chen YH, Gong Y. Cytopathology in the diagnosis of lymphoma. In: Cytology in Oncology. 160. Springer, 211-240, 2014.
10. Gong Y. Breast Cancer: Pathology, Cytology and Core Needle Biopsy methods for diagnosis (Chapter 2). In: Breast and Gynecological Cancers: An Integrated Approach for Screening and Early Diagnosis in Developing Countries. Springer, 19-37, 2013.
11. Gong Y. Ancillary studies on Neoplastic Cytologic Specimens. In: Cytology in Oncology. Springer, 13-29, 2013.
12. Miles LA, Andronicos NM, Felez J, Grella DK, Castellino FJ, Gong Y. The role of Lys-plasminogen in cell-mediated plasmin production. In: Plasminogen: Structure, Activation and Regulation. Kluwer Academic/Plenum Publishers, pp 1-17, 2003.

Books (edited and written)

1. Gong Y. Metastatic Neoplasms in Fine-Needle Aspiration Cytology: Diagnostic Tips and Traps (in Chinese). Springer, 2017.
2. Gong Y. Metastatic Neoplasms in Fine-Needle Aspiration Cytology: Diagnostic Tips and Traps. Springer, 2016.
3. Gan Q, Gong Y. Challenging Cytohistology Cases: Pitfalls and Lessons.

Letters to the Editor

1. Wang J, Gong Y. Metastatic Papillary Thyroid Carcinoma in the Thigh with Unusual Cytologic Features. Diagn Cytopathol 42: 278-79, 2014.
2. Zhao XR, Gong Y. Fine needle aspiration diagnosis of an early onset post-transplant lymphoproliferative disorder. Diagn Cytopathol 39: 788-90, 2011.
3. Angeles R, Gong Y. Seminal vesicle epithelium: a source of diagnostic dilemma in fine-needle aspiration specimen. Diagn Cytopathol 36: 923-24, 2008.
4. Angeles R, Gong Y. Fine-needle aspiration cytology of a rheumatoid arthritis-associated interstitial lung disease. Diagn Cytopathol 36: 686-88, 2008.
5. Ren R, Gong Y. Fine-needle aspiration of a parathyroid hyperplasia with unusual clinical and cytologic presentation. Diagn Cytopathol 35: 250-51, 2007.